“… Outcomes | Exposition to Metal | Ref. |
↑ metal-specific CD154 + CD4 + Tmem (overexpression of TRAV9-2 and CDR3 histidine) | Allergic and non-allergic subjects stimulated with Ni, Co or Pd (PBMC) | [ 67 , 68 ] |
↑ IL-5 | Ni-allergic patients (PBMC) | [ 69 ] |
Ni-allergy patients, differentiation between independent Ni or cross-reactivity of Ni/Pd allergy (PBMC) | [ 71 ] |
Cross reactivity between Ni/Cr and Pd | Sensitization with Ni or Cr, challenge with Pd (mice model) | [ 70 ] |
Skin barrier defects: ↓ terminal differentiation—FLG, FLG2, LOR, LCEs, tight junction—CLDN1/CLDN8, lipid metabolism—FA2H, FABP7 | Biopsies from healthy subjects after Ni-topical application | [ 73 ] |
Cellular infiltrates: ↑ CD3 + T, CD11c + myeloid DC, DC-LAMP + mature DC, MBP + eosinophils, FOXP3 + Treg |
↑ M1, mast cells, neutrophils, NK, CD4 + Tmem, CD8 + T | Biopsies from Ni-allergic patients | [ 74 ] |
↓ M2, resting mast cells, Tγδ, Treg |
↓ SBSN | Ni-allergic patients (serum) | [ 75 ] |
↑ Sema3A (activates MAPK and TNF-α) | Ni-induced allergy (mouse ear tissue) | [ 76 ... |
…”